Cargando…
2525. Identification of lead compounds, belonging to 26-membered thiopeptide antibiotics for new anti-tuberculosis therapeutic agents
BACKGROUND: Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis (Mtb). The incidence of TB patients is increasing globally and the wide spread of multi- and extensively drug-resistant TB poses a significant burden to patients. This situation calls for an urgent medical need...
Autores principales: | Son, Young-Jin, Hwang, Hee-Jong, Shyaka, Clovis, Kim, Dahyun, Lee, Jusuk, Eum, Seokyong, Lee, Sun-Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677219/ http://dx.doi.org/10.1093/ofid/ofad500.2143 |
Ejemplares similares
-
2518. Lead optimization on 26-membered thiopeptide antibiotics and identification of pre-clinical candidates against Clostridioides difficile and Staphylococcus aureus for impetigo
por: Hwang, Hee-Jong, et al.
Publicado: (2023) -
Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target Clostridioides difficile
por: Kim, Dahyun, et al.
Publicado: (2022) -
Thiopeptide Antibiotics: Retrospective and Recent Advances
por: Just-Baringo, Xavier, et al.
Publicado: (2014) -
Therapies from Thiopeptides
por: Hwang, Hee-Jong, et al.
Publicado: (2023) -
Illuminating Siderophore Transporter Functionality with Thiopeptide Antibiotics
por: Dolan, Stephen K.
Publicado: (2023)